Sign inJoin waitlistJoin the waitlist

Jacqueline Bohn

Physician · University of Oklahoma College of Medicine

Credentials: · · · ·

History

University of Oklahoma College of Medicine
2025–Present

Gynecologic Oncology
University of Oklahoma-Health Sciences Center
2021–2024
Obstetrics and Gynecology
Oregon Health & Science University
2017–2021
University of Utah School of Medicine
Univ of Utah Sch of Med
2013–2017

Research

Effects of early daily alcohol exposure on placental function and fetal growth in a rhesus macaque model
American Journal of Obstetrics and Gynecology · 2022 · 18 citations
Demographic and mortality analysis of hospitalized children at a referral hospital in Addis Ababa, Ethiopia
BMC Pediatrics · 2016 · First of 11 authors · Corresponding · 17 citations
Perceived benefits of a transplant surgery experience to general surgery residency training
Journal of surgical education · 2012 · 15 citations

AB
Amanda Bruegl
5 papers
Aaron Caughey
3 papers
AH
Alyssa Hersh
2 papers · 2 as a resident
Benjamin Chou
2 papers
EM
Elizabeth Munro
2 papers
Katherine Fitch
2 papers · 2 as a resident
AE
Amanda Ecker
1 paper
AF
Antonio Frias
1 paper
BM
Brooke Meelheim
1 paper · 1 as a fellow
Daniel Vargo
1 paper
David Record
1 paper
Debra Richardson
1 paper

Clinical trials

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
Site PI · Recruiting
National Cancer Institute (NCI)
2025–2027
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2025–2030
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2025–2031
Clinical Pre-screening Protocol for Ovarian Cancer
Site PI · Recruiting
Allarity Therapeutics
2019–2027